LIFEVANTAGE CORP Shares Outstanding (Cover Page)
LIFEVANTAGE CORP (LFVN) had Shares Outstanding (Cover Page) of 12.53 million shares as of 2026-08-26, per its 10-K filed 2026-08-27.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-27
- 2026-08-26: Entity Common Stock, Shares Outstanding 12.53M shares.
- 2026-05-04: Entity Common Stock, Shares Outstanding 12.62M shares.
- 2026-02-03: Entity Common Stock, Shares Outstanding 12.79M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 12.70M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-26 | 12.53M shares 10-K · filed 2026-08-27 |
| 2026-05-04 | 12.62M shares 10-Q · filed 2026-05-06 |
| 2026-02-03 | 12.79M shares 10-Q · filed 2026-02-04 |
| 2025-11-03 | 12.70M shares 10-Q · filed 2025-11-04 |
| 2025-09-03 | 12.69M shares 10-K · filed 2025-09-04 |
| 2025-05-05 | 12.59M shares 10-Q · filed 2025-05-06 |
| 2025-02-04 | 12.55M shares 10-Q · filed 2025-02-05 |
| 2024-10-28 | 12.53M shares 10-Q · filed 2024-10-29 |
| 2024-08-27 | 12.48M shares 10-K · filed 2024-08-28 |
| 2024-05-01 | 12.70M shares 10-Q · filed 2024-05-02 |
| 2024-01-29 | 12.87M shares 10-Q · filed 2024-01-30 |
| 2023-11-08 | 12.71M shares 10-Q · filed 2023-11-09 |
| 2023-08-25 | 12.70M shares 10-K · filed 2023-08-28 |
| 2023-05-03 | 12.79M shares 10-Q · filed 2023-05-04 |
| 2023-02-01 | 12.72M shares 10-Q · filed 2023-02-02 |
| 2022-11-01 | 12.57M shares 10-Q · filed 2022-11-02 |
| 2022-08-22 | 12.55M shares 10-K · filed 2022-08-23 |
| 2022-04-29 | 12.59M shares 10-Q · filed 2022-05-03 |
| 2022-01-31 | 12.85M shares 10-Q · filed 2022-02-01 |
| 2021-11-01 | 13.24M shares 10-Q · filed 2021-11-04 |
| 2021-08-13 | 13.65M shares 10-K · filed 2021-08-19 |
| 2021-04-23 | 14.00M shares 10-Q · filed 2021-04-29 |
| 2021-01-29 | 14.17M shares 10-Q · filed 2021-02-02 |
| 2020-10-30 | 14.26M shares 10-Q · filed 2020-11-03 |
| 2020-08-14 | 14.35M shares 10-K · filed 2020-08-18 |
| 2020-05-01 | 14.31M shares 10-Q · filed 2020-05-05 |
| 2020-01-24 | 14.36M shares 10-Q · filed 2020-01-28 |
| 2019-10-25 | 13.98M shares 10-Q · filed 2019-10-30 |
| 2019-08-09 | 14.12M shares 10-K · filed 2019-08-14 |
| 2019-04-26 | 14.34M shares 10-Q · filed 2019-05-01 |
| 2019-01-31 | 14.28M shares 10-Q · filed 2019-02-04 |
| 2018-10-26 | 14.10M shares 10-Q · filed 2018-11-01 |
| 2018-08-10 | 14.09M shares 10-K · filed 2018-08-15 |
| 2018-05-04 | 14.31M shares 10-Q · filed 2018-05-09 |
| 2018-02-01 | 14.21M shares 10-Q · filed 2018-02-07 |
| 2017-11-03 | 14.23M shares 10-Q · filed 2017-11-08 |
| 2017-09-01 | 14.23M shares 10-K · filed 2017-09-07 |
| 2017-05-05 | 14.23M shares 10-Q · filed 2017-05-10 |
| 2017-02-03 | 14.10M shares 10-Q · filed 2017-02-08 |
| 2016-11-30 | 14.06M shares 10-K · filed 2016-12-12 |
| 2016-07-15 | 14.03M shares 10-Q/A · filed 2016-07-19 |
| 2016-04-29 | 14.01M shares 10-Q · filed 2016-05-04 |
| 2016-02-05 | 14.01M shares 10-Q · filed 2016-02-09 |
| 2015-10-30 | 14.00M shares 10-Q · filed 2015-11-04 |
| 2015-08-27 | 97.54M shares 10-K · filed 2015-09-01 |
| 2015-04-30 | 97.02M shares 10-Q · filed 2015-05-06 |
| 2015-01-29 | 98.22M shares 10-Q · filed 2015-02-04 |
| 2014-10-30 | 99.29M shares 10-Q · filed 2014-11-06 |
| 2014-09-04 | 100.72M shares 10-K · filed 2014-09-10 |
| 2014-05-01 | 103.70M shares 10-Q · filed 2014-05-06 |
| 2014-02-03 | 103.94M shares 10-Q · filed 2014-02-06 |
| 2013-11-04 | 102.48M shares 10-Q · filed 2013-11-07 |
| 2013-08-31 | 117.62M shares 10-K · filed 2013-09-12 |
| 2013-05-01 | 113.52M shares 10-Q · filed 2013-05-09 |
| 2013-02-01 | 113.67M shares 10-Q · filed 2013-02-07 |
| 2012-11-01 | 113.08M shares 10-Q · filed 2012-11-08 |
| 2012-08-30 | 111.16M shares 10-K · filed 2012-09-10 |
| 2012-05-08 | 110.07M shares 10-Q · filed 2012-05-15 |
| 2012-02-08 | 100.47M shares 10-Q · filed 2012-02-14 |
| 2011-11-01 | 99.30M shares 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |